title: [Infiltrating transitional carcinoma of the bladder. 3. Effect of regional lymph node dissemination on the prognosis].
abstract: The evolution of 168 patients, 136 of which underwent bilateral lymphadenectomy is analyzed in this paper. In 126 cases it was possible to obtain all the data in order to define N within the T.N.M. rating. With regard to the remaining patients 10, of which we lack the anatomopathological report, and 32 which did not undergo lymphadenectomy, are included under item Nx. During follow-up, metastasis was diagnosed in 60% node-positive patients. We believe it to have been already present at the time of undergoing surgery. Survival was significantly higher in the group without node dissemination than in both negative-nodes and Nx groups. When assessing the nodular dissemination group, patients treated with 2000 rad prior to cystectomy showed higher survival rates: 36% vs 22% and 11% for groups treated with 4500 rad and no radiotherapy. respectively. Metastatic percentage, however, was lower for the group managed with surgery alone (50%) than those treated with pre-operative radiotherapy (73% and 67% with 2000 and 4500 rad, respectively), on the other side, it would seem a contradiction that a 2000 rad dosage should be more effective than a 4500 rad dosage for this group of patients, since theoretically, the latter is closer to the ideal dosage to eradicate the nodular disease. Since 3 of 5 patients have micrometastasis, which we are yet unprepared to detect, all positive-node patients should receive chemotherapy immediately after recovery from surgery.
authors.affiliation: Hospital Ramón y Cajal, Servicio de Urología, Madrid.
authors.forename: A
authors.initials: A
authors.lastname: Escudero Barrilero
authors.forename: A
authors.initials: A
authors.lastname: Mateos
authors.forename: E
authors.initials: E
authors.lastname: Maganto
authors.forename: T
authors.initials: T
authors.lastname: Mayayo
authors.forename: I
authors.initials: I
authors.lastname: Pérez Bustamante
authors.forename: I
authors.initials: I
authors.lastname: Fernández
authors.forename: J
authors.initials: J
authors.lastname: del Hoyo
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D002295:Carcinoma, Transitional Cell / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D015653:Cystectomy; D006801:Humans; D015994:Incidence; D015993:Life Tables; D008197:Lymph Node Excision; D008207:Lymphatic Metastasis; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D011379:Prognosis; D011879:Radiotherapy Dosage; D015996:Survival Rate; D001749:Urinary Bladder Neoplasms / Q000401:mortality / Q000473:pathology* / Q000628:therapy
chemical_list: D000970:Antineoplastic Agents
vernacular_title: Carcinoma transicional infiltrante de vejiga. (3a parte). Influencia de la diseminación a ganglios regionales sobre el pronóstico.